Cargando…
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
The p38MAPK signaling pathway was initially described as a stress response mechanism. In fact, during previous decades, it was considered a pathway with little interest in oncology especially in comparison with other MAPKs such as ERK1/2, known to be target of oncogenes like Ras. However, its involv...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928511/ https://www.ncbi.nlm.nih.gov/pubmed/27446920 http://dx.doi.org/10.3389/fcell.2016.00069 |